James Haas serves as Executive at Gala Pharmaceutical Inc., where they oversee executive responsibilities. Since joining the company, James Haas has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 1, 2018 involved receiving (via award) 1,500,000 shares valued at $0.
James Haas currently holds 11,500,000 shares of Gala Pharmaceutical Inc. (GLPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Haas has been a net neutral trader of GLPH stock. They have purchased $0 and sold $0 worth of shares.
James Haas's most recent insider trade was on Nov 1, 2018, when they sold 1,500,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 27, 2016 | GLPH | $0 | Award | 258,334 | $N/A | Discretionary |
| Jan 27, 2016 | GLPH | $0 | Award | 75,000 | $N/A | Discretionary |